Timing of invasive mechanic ventilation in critically ill patients with coronavirus disease 2019

被引:19
|
作者
Zhang, Qian [1 ,2 ]
Shen, Jun [4 ]
Chen, Liangkai [3 ]
Li, Sumeng [1 ,2 ]
Zhang, Wenkai [5 ]
Jiang, Cheng [4 ]
Ma, Haoli [4 ]
Lin, Lian [4 ]
Zheng, Xin [1 ,2 ]
Zhao, Yan [4 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Infect Dis, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Joint Int Lab Infect & Immun, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll,Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety,Minist Educ,Key, Wuhan, Peoples R China
[4] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Hubei, Peoples R China
[5] Huazhong Univ Sci & Technol, Maternal & Child Hlth Hosp Hubei Prov, Tongji Med Coll, Intens Care Unit, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
COVID-19; invasive mechanic ventilation; critically ill; APACHE II; PSI;
D O I
10.1097/TA.0000000000002939
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Invasive mechanical ventilation (IMV) is a lifesaving strategy for critically ill patients with coronavirus disease 2019 (COVID-19). We aim to report the case series of critical patients receiving IMV in Wuhan and to discuss the timing of IMV in these patients. Methods Data of 657 patients admitted to emergency intensive care unit of Zhongnan Hospital and isolated isolation wards of Wuhan Union Hospital from January 1 to March 10, 2020, were retrospectively reviewed. All medical records of 40 COVID-19 patients who required IMV were collected at different time points, including baseline (at admission), before receiving IMV, and before death or hospital discharge. Results Among 40 COVID-19 patients with IMV, 31 died, and 9 survived and was discharged. The median age was 70 years (interquartile range [IQR], 62-76 years), and nonsurvivors were older than survivors. The median period from the noninvasive mechanic ventilation (NIV) or high-flow nasal cannula oxygen therapy (HFNC) to intubation was 7 hours (IQR, 2-42 hours) in IMV survivors and 54 hours (IQR, 28-143 hours) in IMV nonsurvivors. We observed that, when the time interval from NIV/HFNC to intubation was less than 50 hours (about 2 calendar days), together with Acute Physiology and Chronic Health Evaluation II (APACHE II) score of less than 10 or pneumonia severity index (PSI) score of less than 100, mortality can be reduced to 60% or less. Prolonged interval from NIV/HFNC to intubation and high levels of APACHE II and PSI before intubation were associated with higher mortality in critically ill patients. Multiple organ damage was common among these nonsurvivors in the course of treatment. Conclusion Early initial intubation after NIV/HFNC might have a beneficial effect in reducing mortality for critically ill patients meeting IMV indication. Considering APACHE II and PSI scores might help physicians in decision making about timing of intubation for curbing subsequent mortality.
引用
收藏
页码:1092 / 1098
页数:7
相关论文
共 50 条
  • [21] Cytomegalovirus Coinfection in Critically Ill Patients with Novel Coronavirus 2019 Disease: Pathogens or Spectators?
    Siddiqui, Suhail S.
    Chatterjee, Soumyadip
    Yadav, Ambuj
    Rai, Nitin
    Agrawal, Avinash
    Gurjar, Mohan
    Yadav, Geeta
    Prakash, Shantanu
    Kumar, Amit
    Muzaffar, Syed N.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (03) : 375 - 379
  • [22] Impairment of central language processing in critically ill coronavirus disease 2019 patients with delirium
    Ferre, Fabrice
    Buffieres, William
    Heine, Lizette
    Riu, Beatrice
    Curot, Jonathan
    Corneyllie, Alexandra
    Sarton, Benjamine
    Perrin, Fabien
    Silva, Stein
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [23] Hematological ratios in coronavirus disease 2019 patients with and without invasive mechanical ventilation
    Fernandes, Natieli Flores
    Costa, Isabella Ferreira
    Pereira, Karla Nunes
    de Carvalho, Jose Antonio Mainardi
    Paniz, Clovis
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (04) : 321 - 328
  • [24] Cytomegalovirus reactivation in critically-ill Coronavirus Disease 2019 patients: A case series of 11 patients
    Kim, Myeongji
    Jacob, Jeffy
    Mayer, Daniel
    Eckardt, Paula Andrea
    IDCASES, 2022, 27
  • [25] Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature*
    Ong, Jacqueline S. M.
    Tosoni, Alvise
    Kim, YaeJean
    Kissoon, Niranjan
    Murthy, Srinivas
    PEDIATRIC CRITICAL CARE MEDICINE, 2020, 21 (07) : 662 - 666
  • [26] Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review
    Plesoianu, Alexandru Florin
    Plesoianu, Carmen Elena
    Bararu-Bojan , Iris
    Vladeanu , Maria-Cristina
    Bojan, Andrei
    Tarus, Andrei
    Tinica, Grigore
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [27] A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients
    Niazi, Nicholas S.
    Nassar, Tareq I.
    Stewart, Ian J.
    Honore, Patrick M.
    Sharma, Kumar
    Chung, Kevin K.
    ASAIO JOURNAL, 2022, 68 (10) : 1219 - 1227
  • [28] Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
    Yatin Mehta
    Chitra Mehta
    Saurabh Nanda
    Gaurav Kochar
    Joby V. George
    Manish Kumar Singh
    Journal of Medical Case Reports, 15
  • [29] Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
    Mehta, Yatin
    Mehta, Chitra
    Nanda, Saurabh
    Kochar, Gaurav
    George, Joby, V
    Singh, Manish Kumar
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [30] Effects of Glycemic Variability in Critically Ill Patients with Coronavirus Disease 2019: A Retrospective Observational Study
    Boschi, Emerson
    Friedman, Gilberto
    Moraes, Rafael B.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2024, 28 (04) : 381 - 386